CTT Pharmaceutical Holdings, Inc.
CTTH
$0.08
-$0.01-6.25%
OTC PK
| 03/31/2026 | 12/31/2025 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 228.76% | -41.52% | 12,417.65% | 8,180.00% | 408.24% |
| Depreciation & Amortization | 6.25% | 0.00% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 214.46% | -37.55% | 12,417.65% | 8,180.00% | 408.24% |
| Operating Income | -214.46% | 37.55% | -12,417.65% | -8,180.00% | -408.24% |
| Income Before Tax | -187.12% | -7.25% | -19,729.41% | -8,280.00% | -408.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -187.12% | -7.25% | -19,729.41% | -8,280.00% | -408.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -187.12% | -7.25% | -19,729.41% | -8,280.00% | -408.24% |
| EBIT | -214.46% | 37.55% | -12,417.65% | -8,180.00% | -408.24% |
| EBITDA | -228.76% | 38.59% | -- | -- | -- |
| EPS Basic | -180.00% | 0.00% | -17,200.00% | -6,260.00% | -350.00% |
| Normalized Basic EPS | -200.00% | 16.67% | -10,700.00% | -6,533.33% | -325.00% |
| EPS Diluted | -180.00% | 0.00% | -17,200.00% | -6,260.00% | -350.00% |
| Normalized Diluted EPS | -200.00% | 16.67% | -10,700.00% | -6,533.33% | -325.00% |
| Average Basic Shares Outstanding | 5.20% | 10.57% | 30.76% | 32.37% | 5.70% |
| Average Diluted Shares Outstanding | 5.20% | 10.57% | 30.76% | 32.37% | 5.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |